Next Quarterly Earnings
Tuesday, August 11, 2026
CW 33
After-Hours
In 37 days
Veracyte
Veracyte is a leading US-based genomic diagnostics company. It develops and markets advanced tests for precise cancer diagnosis and treatment decisions, particularly for lung and thyroid cancers. The company enhances patient care through innovative biomarker-based precision medicine solutions.
All Dates
Earnings history data not available
Company Information
Name
Veracyte
Country
🇺🇸
More Financial Information